Suchergebnisse - "Liu, Shourong"

PubPharm (78)

11

Arsenic trioxide-artesunate anti-tumor composition, double-drug-loading nano-liposome as well as preparation method and application of double-drug-loading nano-liposome

enthalten in: Europäisches Patentamt | 2023

von PAN XUWANG | ZHUANG RANGXIAO | HUANG JINGSONG | +10

12

pH-Responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma

enthalten in: Drug development and industrial pharmacy | 2023

von Pan, X. | Huang, J. | Liu, S. | +6

13

Exploration of novel dihydroquinoxalinone derivatives as EGFRL858R/T790M tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer

enthalten in: Bioorganic chemistry | 2023

von Cao, Y. | Lu, X. | Fu, L. | +9

14

Liver injury risk prediction system for new crown primary treatment population with normal liver function indexes

enthalten in: Europäisches Patentamt | 2023

von LIU FANG | BAO JIANFENG | HUANG JINGSONG | +5

15

Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021

enthalten in: BMC public health | 2023

von Zuo, Z. | Yang, C. | Ye, F. | +8

16

Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021

enthalten in: BMC public health | 2023

von Zuo, Z. | Yang, C. | Ye, F. | +8

17

Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021

enthalten in: BMC public health | 2023

von Zuo, Z. | Yang, C. | Ye, F. | +8

18

A prediction model for COVID-19 liver dysfunction in patients with normal hepatic biochemical parameters

enthalten in: Life science alliance | 2023

von Bao, J. | Liu, S. | Liang, X. | +17

19

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

enthalten in: Frontiers in immunology | 2023

von Wang, Y. | Li, J. | Zhang, W. | +10

20

Dynamics of CD4+ T-Cells and Neutralizing Antibody Responses to Three Consecutive Doses of Inactivated COVID-19 Vaccines in PLWH

enthalten in: Infection and drug resistance | 2023

von Zhang, W. | Liu, S. | Miao, L. | +6